Zobrazeno 1 - 10
of 65
pro vyhledávání: ''
Autor:
María Teresa Sánchez-Barrón, Ana I. Álvarez-Mercado, Carmen M Ruiz-Marín, Cándido Robles-Sánchez, Saturnino Reyes Lartategui, María José Sáez-Lara, María Belén Sánchez-Andujar, Mariana F. Fernández, Alejandro J. Pérez-Alonso, Ana Moreno-Delgado, Tania Gallart-Aragón, Natalia Chueca, Katia Torres-Martínez, Julio Plaza-Díaz, Federico García, Iris Reina-Pérez, Luis Fontana, Pablo Torné
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer
instname
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer
We would like to thank M Luisa Puertas-Martin and Isabel Manzano-Jimenez, nurses at the Unit of Mammary Pathology, General Surgery Service, San Cecilio University Hospital (Granada), without whose enthusiasm the enrolment of participants in Granada w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8509963333b0ca31ea8159ad28a282
Autor:
Liisa M. Pelttari, Paula Poikonen-Saksela, Kristiina Aittomäki, Päivi Auvinen, Arja Jukkola-Vuorinen, Sanna Hallamies, Heli Nevanlinna, Johanna Mattson, Carl Blomqvist, Antti Jekunen
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-5 (2017)
BMC Cancer
BMC Cancer
Background Several susceptibility genes have been established for female breast cancer, of which mutations in BRCA1 and especially in BRCA2 are also known risk factors for male breast cancer (MBC). The role of other breast cancer genes in MBC is less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4819e7805611ab5361165ecad3b1625
https://erepo.uef.fi/handle/123456789/5171
https://erepo.uef.fi/handle/123456789/5171
Autor:
Jin Seok Ahn, Yoon-La Choi, Hyun Jung Jun, Yeon Hee Park, Myung Hee Chang, Eun Yoon Cho, Min Jae Park, Young-Hyuck Im, Ji Eun Uhm, Do Hyoung Lim, Sang Hoon Ji, Kyoung Ha Kim, Seong Yoon Yi
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 527 (2010)
BMC Cancer, Vol 10, Iss 1, p 527 (2010)
Background We analyzed the responses to first line treatment and clinical outcomes of metastatic breast cancer patients treated with palliative doxorubicin/cyclophosphamide (AC) according to molecular cancer subtype. Methods A retrospective analysis
Publikováno v:
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 260 (2011)
BMC Cancer, Vol 11, Iss 1, p 260 (2011)
Background Our objective was to measure myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML) risk associated with radiation and/or chemotherapy breast cancer (BC) treatment. Methods Our study cohort was composed of BC patients diagnose
Autor:
Riikka Nurminen, Johanna Schleutker, Heli Nevanlinna, Liisa M. Pelttari, Lauri A. Aaltonen, Alexandra E. Gylfe
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 552 (2012)
BMC Cancer
BMC Cancer
Background Rare, heterozygous germline mutations in the RAD51C gene have been found in breast and ovarian cancer families. In the Finnish population, we have identified two founder mutations in RAD51C that increase the risk of ovarian cancer but not
Autor:
Maria A. Loizidou, Panayiotis Papadopoulos, Andreas Hadjisavvas, Rena Papachristoforou, Eleni Kakouri, Simon Malas, Maria Daniel, Kyriacos Kyriacou, Yiola Marcou, Thalia Michael, Nicos Middleton
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 447 (2010)
BMC Cancer
BMC Cancer
Background Breast cancer is the most common form of malignancy affecting women worldwide. It is also the leading cancer in females in Cyprus, with approximately 400 new cases diagnosed annually. It is well recognized that genetic variation as well as
Autor:
Ari T Vaara, Aaron S. Mansfield, Jukka Vakkila, Päivi Heikkilä, Karl von Smitten, Marjut Leidenius
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 231 (2009)
BMC Cancer
BMC Cancer
Background There is evidence that the immune systems of patients with breast cancer are dysfunctional. Regulatory T cells (Tregs), and IDO, an immunosuppressive enzyme, are associated with more advanced disease in some cancers and may promote immunol
Autor:
Lucie Tanneau, Marc Debled, Annie J. Sasco, Virginie Rondeau, Simone Mathoulin-Pélissier, Gaëtan MacGrogan
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2010, 10 (1), pp.697. ⟨10.1186/1471-2407-10-697⟩
BMC Cancer, Vol 10, Iss 1, p 697 (2010)
BMC Cancer, BioMed Central, 2010, 10 (1), pp.697. ⟨10.1186/1471-2407-10-697⟩
BMC Cancer, Vol 10, Iss 1, p 697 (2010)
Background In the setting of recurrent events, research studies commonly count only the first occurrence of an outcome in a subject. However this approach does not correctly reflect the natural history of the disease. The objective is to jointly iden
Autor:
Hossam M. Draz, Nasser M. Al-Daghri, Sobhy M. Yakout, George P. Chrousos, Amal Abdullah Abdulkareem, Abdullah M Alnaami, Amal Alenad, Majed S. Alokail, Shaun Sabico
Publikováno v:
BMC Cancer, Vol 13, Iss 1, p 54 (2013)
BMC Cancer
BMC Cancer
Background Obesity has been linked to many adverse health consequences, including breast cancer. This study aims to determine adipocytokine and other biological changes in recently diagnosed breast cancer patients before therapy is started. Methods A
Autor:
Juliana S. Festa-Vasconcellos, Rosane Vianna-Jorge, Diogo Nascimento Piranda, L.M. Amaral, Anke Bergmann
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 613 (2010)
BMC Cancer, Vol 10, Iss 1, p 613 (2010)
Background Cyclooxygenase-2 (COX-2) is up-regulated in several types of cancer, and it is hypothesized that COX-2 expression may be genetically influenced. Here, we evaluate the association between single-nucleotide polymorphisms (SNPs) in the COX-2